Pfizer Inc. ( PFE) - Stock Earnings
PFE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 29, 2026 BeforeMarket | — / — | — | — / — | — |
PFE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 3.5 billion USD | 16.7 billion USD |
| 2025Q4 | -1.6 billion USD | 17.6 billion USD |
| 2026Q1 | 2.7 billion USD | 14.5 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PFE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.1 billion USD | 59.6 billion USD |
| 2024 | 8.0 billion USD | 63.6 billion USD |
| 2025 | 7.8 billion USD | 62.6 billion USD |
| 2026 Est. | — | — |
PFE
List: Contenders
Price: $25.70
Dividend Yield: 6.78%
Forward Dividend Yield: 6.78%
Payout Ratio: -365.22%
Dividend Per Share: 1.72 USD
Earnings Per Share: 1.31 USD
P/E Ratio: 19.60
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 23.8 million
Ebitda: 3.6 billionMarket Capitalization: 144.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 2.47%
DGR5: 2.81%
DGR10: 4.66%
DGR20: 5.27%